| NSAID type | Target cell type [references] |
| Traditional NSAIDs | | Aspirin | Colon cancer cells [34–36], leukaemia cells [37, 38], cervical cancer cells [39, 40], gastric cancer cells [41–44], hepatocellular carcinoma cells [45, 46], endometrial cancer cells [29], neuroblastoma cells [47] | Indomethacin | Colon cancer cells [7, 35], Gastric cancer cells [44], Endometrial cancer cells [29] | Sulindac | Colon cancer cells [6, 7, 48, 49], prostate cancer cells [48], hepatocellular carcinoma cells [8], lung cancer cells [50] | Ibuprofen | Colon cancer cells [51] | Diclofenac | Neuroblastoma cells [15], melanoma cells [16] | Tolfenamic Acid | Prostate cancer cells [52] | Modified NSAIDs | | NO-Aspirin | Pancreatic cancer cells [53], colon cancer cells [17, 54–58] | NO-sulindac | Colon cancer cells [17], melanoma cells [59] | NO-ibuprofen | Colon cancer cells [17] | NOSH-aspirin | Colon cancer cells [24] | Phosphoaspirin | Colon [19, 21, 56], pancreatic [21], and breast [21] cancer cells | Phosphosulindac | Colon, pancreatic, and breast cancer cells [21] | HS-aspirin | Colon cancer cells [22], breast cancer cells [60] | HS-ibuprofen | Colon cancer cells [22] | HS-naproxen | Colon cancer cells [22] | HS-sulindac | Colon cancer cells [22] |
|
|